Schäffer L
Insulin Research, Novo Nordisk A/S, Bagsvaerd, Denmark.
Eur J Biochem. 1994 May 1;221(3):1127-32. doi: 10.1111/j.1432-1033.1994.tb18833.x.
The affinities of a number of insulin analogues for the human insulin receptor, a truncated soluble form of the insulin receptor, and the human insulin-like growth factor 1 receptor were determined. Insulin analogues with substitutions in the A13 or B17 positions were shown to have anomalous binding properties. This suggests that these positions, which are located in the hexamer-forming surface on the opposite side of the molecule from the classical binding site, constitute a second domain of the molecule important for receptor binding. In the present work, a model is proposed where each of the two alpha subunits of the insulin receptor contributes with a different binding region to the formation of the high-affinity binding site. Subsequently, a second molecule of insulin is able to bind to a low-affinity site involving only one of the alpha subunits, thus accounting for the curvilinear Scatchard plot. The affinity of the low-affinity site could be estimated using a high-affinity insulin analogue as the tracer. The model also provides the framework for a molecular explanation of the negative cooperativity phenomenon.
测定了多种胰岛素类似物与人胰岛素受体、胰岛素受体的截短可溶性形式以及人胰岛素样生长因子1受体的亲和力。结果显示,在A13或B17位有取代的胰岛素类似物具有异常的结合特性。这表明这些位于分子与经典结合位点相对侧的形成六聚体的表面上的位置,构成了分子中对受体结合很重要的第二个结构域。在本研究中,提出了一个模型,其中胰岛素受体的两个α亚基各自以不同的结合区域参与形成高亲和力结合位点。随后,第二个胰岛素分子能够结合到仅涉及一个α亚基的低亲和力位点,从而解释了曲线形的Scatchard图。可以使用高亲和力胰岛素类似物作为示踪剂来估计低亲和力位点的亲和力。该模型还为负协同现象的分子解释提供了框架。